MarDx® Enzyme Immunoassay (EIA) IgG & IgM Test System

HOME >> MEDICINE >> PRODUCTS

Products

MarDx® Enzyme Immunoassay (EIA) IgG & IgM Test System

Company

Trinity Biotech

Item

MarDx® Enzyme Immunoassay (EIA) IgG & IgM Test System

Features

Format : MarDx® 480 Well
Test/Kit : 480 tests
FDA : Cleared
CE : Cleared
Canadian Licensed: : Cleared

Description

MarDx B. burgdorferi Enzyme Immunoassay (EIA) IgG & IgM Test System is a qualitative test intended for use in the presumptive detection of human IgG & IgM antibodies to Borrelia burgdorferi in human serum. This EIA system should be used to test serum from patients with a history and symptoms of infection with B. burgdorferi. All positive and equivocal specimens should be re-tested with a highly specific, second-tier test such as Western blot. Positive second-tier results are supportive evidence of infection with B. burgdorferi. The diagnosis of Lyme disease should be made based on history and symptoms (such as erythema migrans), and other laboratory data, in addition to the presence of antibodies to B. burgdorferi. Negative results (either first or second-tier) should not be used to exclude Lyme disease.

Info

Trinity BiotechCall Trinity Biotech to buy products (US and Canada only; other locations use number below) USA

1-866-328-1174

Customer Service: 1-800-325-3424
Web site: http://www.trinitybiotech.com

TAG: MarDx reg Enzyme Immunoassay EIA IgG IgM Test System

Short examining bridge for insertion of instruments

Designed for accurate articulation of flexible devices.

...PVC, Length 30cm (12") Spiral Tip, 1/56" female th...struments are constructed of a strong but flexible... which allow interchangeability with other brands....hey are also economically priced to give you signi...

It is available in a 5cc-balloon version with round tip and two opposing eyes, and a 30cc-balloon version with two staggered eyes. BARDEX Silicone-Elastomer Foley Catheters are also available in kits

Medicine Products:

S-Series Cystourethroscope Short Bridge, examining P-Series Cystourethroscope Albarran Bridge, single-horn Filiform Spiral Tip BARDEX Silicone-Elastomer 2-Way Foley Catheters

(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...

(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...

(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...

(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...

[0] Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use [0] Medicare Advantage Plans Struggle to Comply With New Federal Law [0] Longs Drug Stores Corporation Reports Second Quarter Results [0] WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History

...annual celebration climaxed Sunday with a vibrant ...ronto's streets Sunday afternoon to enjoy the cit...ration. The parade is Pride Week's signature event...laborate costumes and floats.It was the culminatio...

...d who tested positive for bird flu has recovered f...atment, a doctor said Saturday. The girl, admitte...a island with bird flu symptoms, had contact with ...o tested positive with the disease. "Lab results f...

...ts have been coming to Spain's sun-kissed eastern ...ts among them are connoisseurs of the climate's re... progresses, more and more health "tourists" and f...a of retirement by the sea have been making increa...

...in Chhattisgarh was one of the first to receive re... to ensure sanitation facilities in rural areas . ...t to use them. Each of the 33 families of Dabena i...th latrines constructed near their houses under th...

Other Medicine News:Health News:Biggest Gay Pride Celebration in Toronto 2 Health News:Health Tourists Put Spanish Service Under Strain 2 Health News:'Walk of Shame' Triggers Toilet Consciousness 2 Health News:'Walk of Shame' Triggers Toilet Consciousness 3

Biggest Gay Pride Celebration in Toronto Indonesia Bird Flu Victim in Recovery Health Tourists Put Spanish Service Under Strain 'Walk of Shame' Triggers Toilet Consciousness

(Date:8/18/2008)... - Clinical trial currently in Phase I -,...re/ -- Tobira,Therapeutics Inc., a clinical stage ...d product discovery against life-threatening and l...the issuance of Patent No. 7,371,772,B2 by the U.S... TBR-652, a,CCR5 antagonist currently in Phase I d...

(Date:8/14/2008)... A Complimentary Continuing Education Activi...egalovirus (CMV) is a,significant cause of morbidi...em cell transplantation. The clinical manifestatio...ointestinal disease to life-threatening,pneumonia,...In order to prevent CMV infection and reduce CMV d...

(Date:8/14/2008)... Phase 2 development to begin in late 2008 or in e...ire-FirstCall/ -- Nuvelo, Inc.,(Nasdaq: NUVO ) to...roof-of-concept trial of NU172, demonstrating that...d maintained anticoagulation with a rapid,return t...orable safety,profile., "NU172 has the potential ...

(Date:8/13/2008)...lidates QTinno(TM) - proves the ability to automat...n challenging samples, SANTA CLARA, Calif., Aug. ... Bulletin Board: NWCI) a cardiac diagnostic and se...third external validation study of QTinno(TM),(the...t industry leading,cardiac safety expert with exte...

Breaking Medicine Technology:CMV Disease in Stem Cell Transplantation: Prevention and Drug Resistance 2 Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 2 Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 3 Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 4 NewCardio Announces Positive Results From Third Clinical Validation Study 2 NewCardio Announces Positive Results From Third Clinical Validation Study 3 NewCardio Announces Positive Results From Third Clinical Validation Study 4 NewCardio Announces Positive Results From Third Clinical Validation Study 5 Escalon 28R 29 Reports Financial Results for 2007 Fiscal Year 2401 1 Escalon 28R 29 Reports Financial Results for 2007 Fiscal Year 2401 2 Escalon 28R 29 Reports Financial Results for 2007 Fiscal Year 2401 3 Escalon 28R 29 Reports Financial Results for 2007 Fiscal Year 2401 4 Escalon 28R 29 Reports Financial Results for 2007 Fiscal Year 2401 5 Escalon 28R 29 Reports Financial Results for 2007 Fiscal Year 2401 6 Escalon 28R 29 Reports Financial Results for 2007 Fiscal Year 2401 7 Sanarus Announces Partnership With Leading US Breast Care Physicians for the Next Generation Visica 2 28TM 29 Treatment System for Fibroadenomas 2397 1 Sanarus Announces Partnership With Leading US Breast Care Physicians for the Next Generation Visica 2 28TM 29 Treatment System for Fibroadenomas 2397 2 CCF Reviews Contents of SCHIP Reauthorization Bill Legislation Places SCHIP on Solid Path 2394 1 CCF Reviews Contents of SCHIP Reauthorization Bill Legislation Places SCHIP on Solid Path 2394 2 Community Leaders to Host Press Event at L A Central Jail Urging Governor to Sign AB 1334 2390 1 Community Leaders to Host Press Event at L A Central Jail Urging Governor to Sign AB 1334 2390 2

[0] Tobira Therapeutics Inc. Receives US Patent for TBR-652 [0] CMV Disease in Stem Cell Transplantation: Prevention and Drug Resistance [0] Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 [0] NewCardio Announces Positive Results From Third Clinical Validation Study

...rial in non-small cell lung cancer -, LOS ANGELES,...Genetics, Inc. today announced that positive Phase...f the Journal of Clinical,Oncology suggests that l...ss-Complementing 1 (ERCC-1) in patient biopsies,wi...dicts for,sensitivity to cisplatin-based chemother...

...ul 9, 2007 - TransPharma Medical,Ltd., a specialty...,and commercialization of drug products utilizing ...hnology, announced today,promising results of its ...nd pharmacokinetic profile of its ViaDerm-hPTH (1-...seven day, repeated dose application, parallel gro...

Other Medicine Technology:Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 2 Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 3 Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 4 TransPharma Medical Announces Positive Results of Phase I Clinical,Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis,Treatment 2 TransPharma Medical Announces Positive Results of Phase I Clinical,Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis,Treatment 3

Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer TransPharma Medical Announces Positive Results of Phase I Clinical,Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis,Treatment